Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Peptides Biosimilars market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peptides Biosimilarsmarket, defines the market attractiveness level of Peptides Biosimilars market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peptides Biosimilars industry, describes the types of Peptides Biosimilars market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peptides Biosimilars market and the development prospects and opportunities of Peptides Biosimilars industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peptides Biosimilars market in Chapter 13.
By Player:
Pfizer
Dr Reddy's Laboratories
Sandoz
Stada Arzneimittel AG
Amgen
Teva Pahrmaceutical
Samsung Biologics
Biocon
Mylan
Celltrion
By Type:
Glucagon
Calcitonin
By End-User:
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peptides Biosimilars Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peptides Biosimilars Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peptides Biosimilars Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peptides Biosimilars Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peptides Biosimilars Market Analysis and Outlook to 2022
-
7.1 Global Peptides Biosimilars Consumption (2017-2022)
-
7.2 United States Peptides Biosimilars Consumption (2017-2022)
-
7.3 Europe Peptides Biosimilars Consumption (2017-2022)
-
7.4 China Peptides Biosimilars Consumption (2017-2022)
-
7.5 Japan Peptides Biosimilars Consumption (2017-2022)
-
7.6 India Peptides Biosimilars Consumption (2017-2022)
-
7.7 South Korea Peptides Biosimilars Consumption (2017-2022)
8 Region and Country-wise Peptides Biosimilars Market Analysis and Outlook to 2028
-
8.1 Global Peptides Biosimilars Consumption Forecast (2022-2028)
-
8.2 United States Peptides Biosimilars Consumption Forecast (2022-2028)
-
8.3 Europe Peptides Biosimilars Consumption Forecast (2022-2028)
-
8.4 China Peptides Biosimilars Consumption Forecast (2022-2028)
-
8.5 Japan Peptides Biosimilars Consumption Forecast (2022-2028)
-
8.6 India Peptides Biosimilars Consumption Forecast (2022-2028)
-
8.7 South Korea Peptides Biosimilars Consumption Forecast (2022-2028)
9 Global Peptides Biosimilars Market Outlook by Types and Applications to 2022
-
9.1 Global Peptides Biosimilars Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Glucagon Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Calcitonin Consumption and Growth Rate (2017-2022)
-
9.2 Global Peptides Biosimilars Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Chronic Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Blood Disorders Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Growth Hormone Deficiency Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Other Diseases Consumption and Growth Rate (2017-2022)
10 Global Peptides Biosimilars Market Outlook by Types and Applications to 2028
-
10.1 Global Peptides Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Glucagon Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Calcitonin Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peptides Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Chronic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Growth Hormone Deficiency Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)
11 Global Peptides Biosimilars Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peptides Biosimilars Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peptides Biosimilars Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peptides Biosimilars Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peptides Biosimilars Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Peptides Biosimilars Product and Service
-
14.2 Dr Reddy's Laboratories
-
14.2.1 Dr Reddy's Laboratories Company Details
-
14.2.2 Dr Reddy's Laboratories Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Dr Reddy's Laboratories Peptides Biosimilars Product and Service
-
14.3 Sandoz
-
14.3.1 Sandoz Company Details
-
14.3.2 Sandoz Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sandoz Peptides Biosimilars Product and Service
-
14.4 Stada Arzneimittel AG
-
14.4.1 Stada Arzneimittel AG Company Details
-
14.4.2 Stada Arzneimittel AG Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Stada Arzneimittel AG Peptides Biosimilars Product and Service
-
14.5 Amgen
-
14.5.1 Amgen Company Details
-
14.5.2 Amgen Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Peptides Biosimilars Product and Service
-
14.6 Teva Pahrmaceutical
-
14.6.1 Teva Pahrmaceutical Company Details
-
14.6.2 Teva Pahrmaceutical Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Teva Pahrmaceutical Peptides Biosimilars Product and Service
-
14.7 Samsung Biologics
-
14.7.1 Samsung Biologics Company Details
-
14.7.2 Samsung Biologics Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Samsung Biologics Peptides Biosimilars Product and Service
-
14.8 Biocon
-
14.8.1 Biocon Company Details
-
14.8.2 Biocon Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Biocon Peptides Biosimilars Product and Service
-
14.9 Mylan
-
14.9.1 Mylan Company Details
-
14.9.2 Mylan Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Mylan Peptides Biosimilars Product and Service
-
14.10 Celltrion
-
14.10.1 Celltrion Company Details
-
14.10.2 Celltrion Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Celltrion Peptides Biosimilars Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peptides Biosimilars
-
Figure Peptides Biosimilars Picture
-
Table Global Peptides Biosimilars Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptides Biosimilars Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptides Biosimilars Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peptides Biosimilars Consumption by Country (2017-2022)
-
Figure United States Peptides Biosimilars Consumption and Growth Rate (2017-2022)
-
Table Europe Peptides Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure China Peptides Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Japan Peptides Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure India Peptides Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peptides Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Global Peptides Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure United States Peptides Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peptides Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peptides Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peptides Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peptides Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peptides Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glucagon Consumption and Growth Rate (2017-2022)
-
Figure Global Calcitonin Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormone Deficiency Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Glucagon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcitonin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormone Deficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peptides Biosimilars Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peptides Biosimilars Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Peptides Biosimilars Product and Service
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Peptides Biosimilars Product and Service
-
Table Sandoz (Foundation Year, Company Profile and etc.)
-
Table Sandoz Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz Peptides Biosimilars Product and Service
-
Table Stada Arzneimittel AG (Foundation Year, Company Profile and etc.)
-
Table Stada Arzneimittel AG Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stada Arzneimittel AG Peptides Biosimilars Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Peptides Biosimilars Product and Service
-
Table Teva Pahrmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pahrmaceutical Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pahrmaceutical Peptides Biosimilars Product and Service
-
Table Samsung Biologics (Foundation Year, Company Profile and etc.)
-
Table Samsung Biologics Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Samsung Biologics Peptides Biosimilars Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Peptides Biosimilars Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Peptides Biosimilars Product and Service
-
Table Celltrion (Foundation Year, Company Profile and etc.)
-
Table Celltrion Peptides Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Peptides Biosimilars Product and Service
-
